Tectonic Therapeutic | AVRO - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Celltrion KRW 78.68B 25.51B 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Gilead Sciences USD 645M 70M 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
MacroGenics USD 4.29M 500K 2026-03
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Ovoca Bio EUR 186K 23K 2025-06
Pfizer USD 4.51B 734M 2026-03
Pharma Mar EUR 43.83M 10.51M 2026-03
Qiagen NV USD 72.66M 2.11M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Takeda JPY 491.34B 23.75B 2026-03
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03